Crossmark

Impact of drug substitution on cost of care: an example of economic analysis of cetuximab versus panitumumab

Crossref DOI link: https://doi.org/10.1186/s12962-018-0132-9

Published Online: 2018-11-12

Published Print: 2018-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Xu, Yifan

Hay, Joel W.

Barzi, Afsaneh https://orcid.org/0000-0002-0032-2988
License Information

Text and Data Mining valid from 2018-11-12
More Information

Article History

Received: 20 April 2018

Accepted: 21 August 2018

First Online: 12 November 2018